Riding the Opportunity Pipeline

You sometimes hear chat about a "pipeline" of new tests for QuantiFERON.


Here are a couple of QuantiFERON "maybes," Hepatitis

This novel, inexpensive assay detected significantly lower specific and global immune responses in patients with advanced recurrent HCV post-LT.

and toxoplasmosis.

These preliminary data according with a previous paper by Peyron et al. suggest that also this commercial test could be useful in early diagnosis of congenital toxoplasmosis and in all cases in which serological test cannot solve diagnostic problems.

Qiagen also has an interest in TB, hepatitis and in congenital toxoplasmosis and QuantiFERON could be helpful in the pre molecular phase.